Best STD Specialist for Women in Kathmandu — Women's Sexual Health Silent Infections, PID, Pregnancy & Cervical Screening

Women's STI Care — Where the Stakes Are Different

Women's sexual health carries a different risk profile than men's — anatomy is different (an ascending infection produces PID rather than epididymitis), silent fraction is larger (~70% of chlamydia in women vs a lower but still large fraction in men), and reproductive consequences are more severe (tubal infertility, ectopic pregnancy, congenital transmission).

This means screening logic differs: women benefit more from proactive routine screening precisely because consequences of missed silent infection are higher, and because presentations are quieter. A woman with chlamydia often has no symptoms until the PID that follows — screening interval is what catches it before ascent.

At Thamel Clinic, women's sexual health covers full range: infection-specific care, the PID work-up, pregnancy screening and pregnancy-safe management, cervical screening for HPV, and contraception and fertility counselling that surrounds it.

The Silent Majority

~70% of chlamydia in women produces no symptoms — infection ascends silently to uterus and tubes before any warning appears. Most early syphilis is unnoticed ( primary chancre is painless and often internal). Most HPV is asymptomatic. Much herpes is unrecognized.

The consequence: a woman cannot rely on symptoms to know whether she is infected — screening interval (annually baseline, ~3–6 months for higher risk) is what finds infection while it is still curable without consequence.

PID — the Fertility Threat

PID — pelvic inflammatory disease — is ascending infection of uterus, tubes and ovaries, usually from chlamydia or gonorrhea. ~10–15% of untreated chlamydia progresses to PID; each episode raises risk of tubal infertility ~10–20%, multiplies ectopic risk, and can produce chronic pelvic pain.

The protection is upstream: screening catches chlamydia while it is still cervical and curable — before it ascends. Once PID is present, early empiric treatment limits damage; infertility and ectopic risk are what late or missed treatment produces.

Pregnancy & Prenatal Screening

In pregnancy, STI screening is part of prenatal care because consequences extend to baby: chlamydia transmits at delivery (neonatal eye and lung infection), syphilis produces congenital disease (preventable with early treatment — stillbirth and congenital syphilis risks are why syphilis screening is standard in pregnancy), hepatitis B transmits vertically (neonatal vaccination prevents most), and HIV requires managed care for safe delivery.

Treatment in pregnancy is adjusted to pregnancy-safe regimens — most treatments have safe alternatives; consultation identifies which apply.

Cervical & Other Screening

Cervical screening — HPV DNA testing ± cytology — is cancer-prevention core of women's sexual health: detecting high-risk HPV persistence and early cell changes before they become cancer. Screening intervals are typically ~3–5 years for negative co-tests, shorter where results warrant.

Beyond cervical: BV assessment ( commonest discharge cause, with pregnancy implications), trichomoniasis ( true STI in discharge differential), candida assessment, and hormonal and fertility evaluations that broader service covers.

Women's Services & Costs

Transparent pricing; confirm when booking.

Related Services & Guides